Valuation Lundbeck Nasdaq Copenhagen

Stocks

Real-time Estimate Cboe Europe 02:39:35 23/10/2026 pm IST			5-day change	1st Jan Change
48.60 ^DKK	+0.83%		+7.99%	+34.39%

21/10	BNP Paribas raises price target for Lundbeck to 48 Danish kroner (46), reiterates neutral	FW
19/10	Lundbeck proposes former Novo Nordisk CEO as new chairman	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	25,433	31,719	39,416	41,398	50,392	-	-
Change	-	24.72%	24.27%	5.03%	21.73%	-	-
Enterprise Value (EV) ¹	27,464	31,008	51,598	49,619	54,354	50,205	46,377
Change	-	12.91%	66.4%	-3.84%	9.54%	-7.63%	-7.62%
P/E	13.5x	14.2x	13x	13.4x	11.3x	11.1x	11.7x
PBR	1.24x	1.47x	1.64x	1.72x	1.79x	1.61x	1.47x
PEG	-	0.7x	0.3x	8.5x	0.3x	7.09x	-2.08x
Capitalization / Revenue	1.39x	1.59x	1.79x	1.68x	1.94x	1.92x	1.97x
EV / Revenue	1.51x	1.56x	2.34x	2.01x	2.1x	1.92x	1.81x
EV / EBITDA	5.89x	5.49x	8.13x	6.3x	6.64x	6.13x	5.97x
EV / EBIT	9.63x	9.71x	15.8x	9.41x	8.88x	8.02x	7.86x
EV / FCF	10.2x	8.66x	18.7x	10.2x	9.25x	8.23x	8.3x
FCF Yield	9.83%	11.5%	5.35%	9.8%	10.8%	12.1%	12.1%
Dividend per Share ²	0.58	0.7	0.95	1.15	1.566	1.406	1.521
Rate of return	2.23%	2.14%	2.3%	2.66%	3.04%	2.73%	2.95%
EPS ²	1.93	2.31	3.17	3.22	4.577	4.649	4.388
Distribution rate	30.1%	30.3%	30%	35.7%	34.2%	30.2%	34.7%
Net sales ¹	18,246	19,912	22,004	24,630	25,921	26,195	25,573
EBITDA ¹	4,663	5,652	6,347	7,881	8,182	8,191	7,765
EBIT ¹	2,852	3,195	3,270	5,275	6,120	6,261	5,899
Net income ¹	1,916	2,290	3,143	3,192	4,603	4,649	4,308
Net Debt ¹	2,031	-711	12,182	8,221	3,962	-187.5	-4,015
Reference price ²	26.05	32.76	41.32	43.16	51.50	51.50	51.50
Nbr of stocks (in thousands)	9,92,840	9,92,840	9,92,011	9,91,227	9,91,227	-	-
Announcement Date	07/02/23	07/02/24	05/02/25	04/02/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	37.7x	13.43x	28.51x	0.52%	1,16500Cr
JOHNSON & JOHNSON	39.17x	6.59x	18.54x	1.99%	64TCr
ABBVIE INC.	36.4x	8.37x	17.27x	2.41%	50TCr
ROCHE HOLDING AG	20.97x	5.15x	12.78x	2.55%	38TCr
MERCK & CO., INC.	107.33x	5.99x	25.72x	2.31%	36TCr
NOVARTIS AG	21.95x	5.71x	14.04x	2.79%	30TCr
ASTRAZENECA PLC	22.67x	4.58x	13.09x	1.93%	27TCr
AMGEN INC.	28.38x	7.14x	12.79x	2.26%	24TCr
GILEAD SCIENCES, INC.	-45.82x	7.02x	27.23x	2.1%	19TCr
Average	29.86x	7.11x	18.89x	2.1%	45.06TCr
Weighted average by Cap.	35.73x	8.44x	20.74x	1.78%